These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey. Espinal MA, Báez J, Soriano G, Garcia V, Laszlo A, Reingold AL, Sanchez S. Int J Tuberc Lung Dis; 1998 Jun; 2(6):490-8. PubMed ID: 9626607 [Abstract] [Full Text] [Related]
25. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus. Kam KM, Yip CW. Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147 [Abstract] [Full Text] [Related]
26. Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation. Spradling P, Nemtsova E, Aptekar T, Shulgina M, Rybka L, Wells C, Aquino G, Kluge H, Jakubowiak W, Binkin N, Kazeonny B. Int J Tuberc Lung Dis; 2002 Sep; 6(9):757-62. PubMed ID: 12234130 [Abstract] [Full Text] [Related]
27. Prevalence of primary multidrug resistance to anti-tuberculosis drugs in Pakistan. Javaid A, Hasan R, Zafar A, Ghafoor A, Pathan AJ, Rab A, Sadiq A, Akram CM, Burki I, Shah K, Ansari M, Rizvi N, Khan SU, Awan SR, Syed ZA, Iqbal ZH, Shaheen Z, ur Rehman N. Int J Tuberc Lung Dis; 2008 Mar; 12(3):326-31. PubMed ID: 18284840 [Abstract] [Full Text] [Related]
28. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Umubyeyi AN, Vandebriel G, Gasana M, Basinga P, Zawadi JP, Gatabazi J, Pauwels P, Nzabintwali F, Nyiramasarabwe L, Fissette K, Rigouts L, Struelens MJ, Portaels F. Int J Tuberc Lung Dis; 2007 Feb; 11(2):189-94. PubMed ID: 17263290 [Abstract] [Full Text] [Related]
34. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. Park SK, Kim CT, Song SD. Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607 [Abstract] [Full Text] [Related]
36. Tuberculosis control in Bangladesh: success of the DOTS strategy. Kumaresan JA, Ahsan Ali AK, Parkkali LM. Int J Tuberc Lung Dis; 1998 Dec; 2(12):992-8. PubMed ID: 9869115 [Abstract] [Full Text] [Related]
37. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR, Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS. Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407 [Abstract] [Full Text] [Related]
38. Nationwide study of drug resistance among acid-fast bacilli positive pulmonary tuberculosis cases in Lebanon. Araj GF, Saade M, Itani LY. Int J Tuberc Lung Dis; 2006 Jan; 10(1):63-7. PubMed ID: 16466039 [Abstract] [Full Text] [Related]
39. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Teixeira L, Perkins MD, Johnson JL, Keller R, Palaci M, do Valle Dettoni V, Canedo Rocha LM, Debanne S, Talbot E, Dietze R. Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250 [Abstract] [Full Text] [Related]
40. Tuberculosis in Thailand: epidemiology and program performance, 2001-2005. Jittimanee S, Vorasingha J, Mad-asin W, Nateniyom S, Rienthong S, Varma JK. Int J Infect Dis; 2009 Jul; 13(4):436-42. PubMed ID: 19013094 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]